×
Accedi
Iniziamo
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Esplora tutte le categorie
Report -
NUOVI VACCINI E NUOVE STRATEGIE VACCINALI• In January 2005, FDA licensed a new tetravalent (serogroups A, C, Y, W-135) meningococcal conjugate vaccine (MCV4) for use in persons 11-55
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form